Literature DB >> 32550179

High-dose thiamine supplementation may reduce resting energy expenditure in individuals with hyperglycemia: a randomized, double - blind cross-over trial.

Fariba Alaei-Shahmiri1, Mario J Soares2, Maryam Lahouti1, Yun Zhao2, Jill Sherriff2.   

Abstract

BACKGROUND: Despite the crucial role of thiamine in glucose and energy metabolism pathways, there has been no published study examining the impact of thiamine on energy metabolism in humans.
OBJECTIVE: To assess the effects of thiamine supplementation on resting energy expenditure (REE) in individuals with hyperglycemia.
METHODS: Twelve hyperglycemic patients completed this double-blind, randomized trial, where all participants received both thiamine (300 mg/day) and matched placebo for 6 weeks in a cross-over manner. REE was assessed by indirect calorimetry. Anthropometric measurements, fasting and 2-h plasma glucose, and glucose-induced thermogenesis were also assessed at the beginning and on the completion of each six-week phase.
RESULTS: Participants consuming thiamine supplements experienced a significant decrease in the REE assessed at week six compared to the baseline [mean (SE): 1478.93 (73.62) vs.1526.40 (73.46) kcal/d, p = 0.02], and the placebo arm (p = 0.002). These results did not change significantly after adjusting for the participants' body weight and physical activity as potential confounders. Six-week intervention had no significant effect on the participants' body weight or waist circumference, in either supplement or placebo arms (all p values>0.05). However, correlation analysis highlighted significant positive relationships between the changes in REE, and those in fasting (rs = 0.497, p = 0.019) and 2-h plasma glucose (rs = 0.498, p = 0.018) during the six-week intervention period.
CONCLUSION: Supplementation with high-dose thiamine may attenuate REE in patients with impaired glucose regulation. Our findings suggest that the impact of thiamine on REE may in part be explained by improved glycemic control. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12611000051943. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000051943. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Blood glucose; Body weight; Diabetes mellitus; Energy expenditure; Energy metabolism; Glucose intolerance; Hyperglycemia; Thiamine; Vitamin B1

Year:  2020        PMID: 32550179      PMCID: PMC7271085          DOI: 10.1007/s40200-020-00508-1

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  32 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Thiamine deficiency induces anorexia by inhibiting hypothalamic AMPK.

Authors:  M Liu; A P Alimov; H Wang; J A Frank; W Katz; M Xu; Z-J Ke; J Luo
Journal:  Neuroscience       Date:  2014-03-05       Impact factor: 3.590

3.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

4.  Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.

Authors:  Elena Berrone; Elena Beltramo; Carmela Solimine; Alessandro Ubertalli Ape; Massimo Porta
Journal:  J Biol Chem       Date:  2006-02-01       Impact factor: 5.157

5.  Inactivation of the AMP-activated protein kinase by glucose in cardiac myocytes: a role for the pentose phosphate pathway.

Authors:  Ikhlass Tabidi; David Saggerson
Journal:  Biosci Rep       Date:  2012-06       Impact factor: 3.840

6.  The impact of thiamine supplementation on blood pressure, serum lipids and C-reactive protein in individuals with hyperglycemia: a randomised, double-blind cross-over trial.

Authors:  F Alaei-Shahmiri; M J Soares; Y Zhao; J Sherriff
Journal:  Diabetes Metab Syndr       Date:  2015-04-29

7.  Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

Authors:  A Consoli; N Nurjhan; F Capani; J Gerich
Journal:  Diabetes       Date:  1989-05       Impact factor: 9.461

Review 8.  Energy Expenditure in People with Diabetes Mellitus: A Review.

Authors:  Nathan Caron; Nicolas Peyrot; Teddy Caderby; Chantal Verkindt; Georges Dalleau
Journal:  Front Nutr       Date:  2016-12-22

9.  The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor.

Authors:  Andrew McBride; Stephanos Ghilagaber; Andrei Nikolaev; D Grahame Hardie
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

Review 10.  AMPK activation: a therapeutic target for type 2 diabetes?

Authors:  Kimberly A Coughlan; Rudy J Valentine; Neil B Ruderman; Asish K Saha
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-24       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.